TSS
LABD icon

Two Sigma Securities’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Two Sigma Securities’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,186
Closed -$762K – 1944
2025
Q4 		$762K Buy
36,186
+21,750
+151% +$590K 0.1% 254
2025
Q3 		$584K Buy
+14,436
New +$836K 0.09% 316
2025
Q1 		– Sell
-6,119
Closed -$444K – 1870
2024
Q4 		$444K Buy
+6,119
New +$374K 0.06% 426
2024
Q3 		– Sell
-12,031
Closed -$882K – 3287
2024
Q2 		$882K Buy
12,031
+10,711
+811% +$904K 0.01% 1154
2024
Q1 		$96.2K Buy
+1,320
New +$110K ﹤0.01% 2483
2023
Q2 		– Sell
-1,795
Closed -$370K – 3097
2023
Q1 		$370K Buy
+1,795
New +$305K 0.01% 1499
2022
Q2 		– Sell
-1,193
Closed -$418K – 2570
2022
Q1 		$418K Buy
1,193
+201
+20% +$78.8K 0.01% 1142
2021
Q4 		$255K Buy
+992
New +$228K 0.01% 918
2018
Q3 		– Sell
-40
Closed -$210K – 2822
2018
Q2 		$210K Buy
+40
New +$243K ﹤0.01% 2328
2017
Q3 		– Sell
-38
Closed -$526K – 1081
2017
Q2 		$526K Buy
38
+27
+245% +$519K 0.1% 195
2017
Q1 		$227K Buy
11
+5
+83% +$124K 0.04% 552
2016
Q4 		$242K Buy
+6
New +$231K 0.08% 334

Other funds holding LABD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Securities's LABD Position: Q1 2026 in Review

Two Sigma Securities sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2026, closing a stake of 36,186 shares — an estimated $762K sold.

Two Sigma Securities first reported a position in LABD in Q4 2016 and held it in 12 quarters. The position peaked at $882K in Q2 2024. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

  • Two Sigma Securities reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 36,186 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $762K.
  • Two Sigma Securities first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2016 and held it in 12 quarters.
  • Two Sigma Securities's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $882K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.